T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

Clinical trial NCT06157541 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06157541
Sponsor: Queensland Institute of Medical Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Astrocytoma, Grade IV

Start date: 2024-02-08
Primary completion: 2025-10-02
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.